CLINICAL STUDY ON LIFEMAX'S MILA RELEASED
Posted Feb. 11th, 2009ORLANDO, Fla. Lifemax announced the preliminary results of a study commissioned to evaluate the effect that Mila would have on people with elevated levels of cholesterol, particularly the bad cholesterol, LDL. The study was conducted by The University of Texas Health Science Center at Houston and the results released on February 7th in Orlando. We were thrilled to have an institution as well-regarded as The University of Texas Health Science Center to perform this study, said Paul Rogers, Lifemaxs Chief Executive Officer. The results exceeded our expectations!
Download the Entire Article - uploads/docs/LMLifemaxClinicalStudy.pdf